Body Contouring Treatments Market: Growth, Size, Share, and Trends

Report Code MD 9199
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Body Contouring Treatments Market by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), and End user - Global Forecast to 2029

Overview

The global body contouring treatments market, valued at US$1.33 billion in 2023, is forecasted to grow at a robust CAGR of 10.0%, reaching US$1.46 billion in 2024 and an impressive US$2.58 billion by 2029. A major driver is the growing adoption of minimally invasive and non-invasive body contouring procedures. The increasing demand for aesthetic treatments among male patients has led to the increasing demand for treatments related to body contouring. Moreover, rising disposable income in emerging economies, coupled with expanding access to various healthcare services, supports the demand for body contouring treatments.

Attractive Opportunities in the Body Contouring Treatments Market

North America

North America is expected to be lead the market, owing to the high healthcare spending, increase in medical tourism, and technological advancements in body contouring devices.

The market growth globally can be attributed to the rising number of body contouring procedures and the growing adoption of non-invasive and invasive body contouring treatments.

Increasing target population and rising healthcare expenditure may create opportunities for market players in the next five years.

Europe is the second-largest market for body contouring treatments due to rising social media influence.

Emerging economies, such as India and China, offer several opportunities for the growth of the body contouring treatments market.

Global Body Contouring Treatments Market Dynamics

DRIVER: Growing adoption of minimally invasive and non-invasive body contouring procedures

The growing adoption of minimally invasive and non-invasive procedures is a major factor driving the global demand for body contouring procedures. Compared to standard surgical procedures, minimally invasive and non-invasive procedures tend to have several benefits, such as causing less discomfort and scarring and faster recovery. These procedures are less expensive than conventional surgical methods. Therefore, minimally invasive techniques cause fewer complications and potentially lead to similar results as surgery.

RESTRAINT: High cost and lack of reimbursement policy

Premium pricing is a restraining factor for the adoption in emerging countries. The financial cost hinders many potential clients from undergoing these treatments. Thus, the growth rate of the market is slowed because some treatments are no longer accessible and affordable to a larger patient pool. This aspect of finance impacts the demand for procedures and impacts the growth of this market. High treatment costs and lack of a reimbursement policy restrain the body contouring treatments market.

 

OPPORTUNITY: Growth potential in emerging economies

Emerging economies, such as Brazil, Russia, India, and several Latin American and Southeast Asian countries, are expected to offer lucrative growth opportunities to players operating in the body contouring treatments market. Improved healthcare infrastructure and a growing focus on hospital care in these countries would drive the demand and adoption of body contouring devices. The demand for body contouring treatments in these countries has increased due to rapid medical tourism growth, increasing disposable income, and growing awareness about aesthetic specialties.

CHALLENGES: Social and cultural barriers

Social stigmas associated with body contouring treatments (surgical and non-surgical) are due to negative perceptions toward body contouring procedures and religious and ethical concerns related to some treatments, such as alterations of shape. Despite the increasing emphasis on looking younger among the elderly, there are possible negative social consequences related to cosmetic age concealment. The social stigma attached to body contouring treatments negatively affects the social acceptance of these procedures. Privacy concerns prevent open discussions, limiting awareness and increasing stigma.

Global Body Contouring Treatments Market Ecosystem Analysis

The body contouring treatments market has a dynamic ecosystem. The infographic includes all kinds of body contouring device providers, end users, and distributors in the market. The device manufacturers play a crucial role in developing innovative equipment based on various technologies. Distributors facilitate access to this equipment for different end users in the market. The ecosystem helps to streamline the product availability and supply chain.

 

By technology, the non-invasive technologies segment accounted for the largest share in 2023.

Based on technology, the body contouring treatments market is segmented into invasive technologies and non-invasive technologies. In 2023, the non-invasive technologies segment accounted for the largest market share. Increasing organic and inorganic development strategies by the key players, product launches, and approvals propels the growth of the segment. The launch of innovative products with improved features by key market players also fuels the growth of the body contouring treatments market. A wider range of target population, increased comfort, and affordability of the treatments have led to increased adoption of non-invasive treatments.

By application, the non-surgical fat reduction accounted for the largest share in 2023.

Based on application, the body contouring treatments market is segmented into non-surgical fat reduction, cellulite treatment, liposuction, abdominoplasty, and other applications. In 2023, the non-surgical fat reduction segment accounted for the largest market share. The preference for non-surgical fat reduction procedures has grown due to their convenience and comfort. Elderly individuals seeking non-invasive methods for stubborn fat reduction and younger people seeking preventative therapies also support the growth of this segment.

North America Accounted for the Largest of the Market in 2023

North America accounted for the largest of the market in 2023. The large share of the body contouring treatments market in North America is because the region is attributed to technological leadership, robust healthcare infrastructure, growing funding and grants for developing advanced medical equipment, favorable regulatory scenarios, strategic research collaboration, and a supportive market environment fostering innovations.

HIGHEST CAGR MARKET IN 2023
ASIA_PACIFC FASTEST GROWING MARKET IN THE REGION

Recent Developments of Body Contouring Treatments Market

  • In April 2024, Cynosure LLC (US) merged with Lutronic (South Korea) to provide innovative products and customer service to aesthetic providers.
  • In December 2023, Venus Concept (US) collaborated with Spectra Medical Systems (India) to expand its distribution network and provide customer and technical support.
  • In December 2023, Venus Concept (US) collaborated with Core Aesthetics Skin & Laser Limited (UK) to provide sales, services, and training in the UK.
  • In March 2022, Cynosure LLC (US) and Jeisys Medical Inc. (Japan) partnered to establish the distribution channel for the energy-based laser portfolio of Cynosure in the Japanese market.

Key Market Players

Want to explore hidden markets that can drive new revenue in Body Contouring Treatments Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered Technology, patient type, application, end user, and region
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Questions Addressed by the Report

The global body contouring treatments market is projected to grow from USD 1.46 billion in 2024 to USD 2.58 billion by 2029, demonstrating a robust CAGR of 10.0%.
The growing adoption of minimally invasive and non-invasive body contouring procedures, as well as increasing demand for aesthetic treatments, especially among male patients, are key factors driving market growth.
The body contouring treatments market is expected to see significant growth in emerging economies like Brazil, Russia, India, and Southeast Asia due to rising disposable income, medical tourism, and expanding healthcare infrastructure.
The high cost of treatments and lack of reimbursement policies are key challenges affecting the growth of the body contouring treatments market, especially in emerging markets.
Non-invasive technologies accounted for the largest share of the body contouring treatments market in 2023, due to their comfort, affordability, and increasing adoption in a wide range of target populations.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Body Contouring Treatments Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
25
RESEARCH METHODOLOGY
29
EXECUTIVE SUMMARY
41
PREMIUM INSIGHTS
45
MARKET OVERVIEW
49
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing adoption of minimally invasive and non-invasive body contouring procedures
    - Increasing demand for aesthetic treatments among men
    - Rising adoption of new and innovative body contouring technologies
    - Widespread social media influence and cultural changes
    RESTRAINTS
    - High cost of treatment and inadequate reimbursement policies
    OPPORTUNITIES
    - Growth potential in emerging economies
    CHALLENGES
    - Social and cultural barriers
    - Stringent regulatory compliance and safety standards
  • 5.3 VALUE CHAIN ANALYSIS
    RESEARCH & PRODUCT DEVELOPMENT
    RAW MATERIAL PROCUREMENT AND MANUFACTURING
    DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.4 SUPPLY CHAIN ANALYSIS
    MANUFACTURERS
    - Prominent companies
    - Small and medium-sized enterprises
    END USERS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    REGULATORY APPROVALS
    KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
    AVERAGE SELLING PRICE TREND OF BODY CONTOURING DEVICES, BY REGION
  • 5.10 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.11 PATENT ANALYSIS
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.14 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.15 CASE STUDY ANALYSIS
    IMPROVED FAT REDUCTION PROCEDURES USING LARGER APPLICATOR
    ENHANCED SUPPLY CHAIN AND OPERATIONAL EFFICIENCY WITH HIGHER RESEARCH & DEVELOPMENT
  • 5.16 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Thermal technologies
    - Non-thermal technologies
    COMPLEMENTARY TECHNOLOGIES
    - Skin cooling systems
    ADJACENT TECHNOLOGIES
    - Treatment planning software
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.18 UNMET NEEDS
  • 5.19 IMPACT OF AI/GEN AI ON BODY CONTOURING TREATMENTS MARKET
    KEY USE CASES
BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY
95
  • 6.1 INTRODUCTION
  • 6.2 INVASIVE TECHNOLOGIES
    INVASIVE RADIOFREQUENCY TECHNOLOGY
    - Growing inclination toward skin tightening to propel market
    INVASIVE LASER TECHNOLOGY
    - Higher advantages compared to traditional techniques to speed up growth
    INVASIVE ULTRASOUND TECHNOLOGY
    - Targeted fat reduction and minimal discomfort to augment growth
  • 6.3 NON-INVASIVE TECHNOLOGIES
    NON-INVASIVE RADIOFREQUENCY TECHNOLOGY
    - Rising use of cellulite treatment, fat reduction, and skin tightening to drive market
    NON-INVASIVE LASER TECHNOLOGY
    - Growing adoption in hospitals and aesthetic clinics to fuel market
    NON-INVASIVE ULTRASOUND TECHNOLOGY
    - Need for precise temperature management control to accelerate growth
    CRYOLIPOLYSIS TECHNOLOGY
    - Low risk and minimal side effects to facilitate growth
    OTHER NON-INVASIVE TECHNOLOGIES
BODY CONTOURING TREATMENTS MARKET, BY GENDER
107
  • 7.1 INTRODUCTION
  • 7.2 FEMALE PATIENTS
    GROWING USE OF BODY CONTOURING TO ADDRESS POST-SURGICAL CHANGES TO BOOST MARKET
  • 7.3 MALE PATIENTS
    INCREASING SHIFT IN SOCIAL AND AESTHETIC STANDARDS TO EXPEDITE GROWTH
BODY CONTOURING TREATMENTS MARKET, BY APPLICATION
111
  • 8.1 INTRODUCTION
  • 8.2 NON-SURGICAL FAT REDUCTION
    GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET
  • 8.3 CELLULITE REDUCTION
    RISING OBESITY RATES TO SUPPORT MARKET GROWTH
  • 8.4 LIPOSUCTION
    GROWING DEMAND FOR COSMETIC ENHANCEMENT WITH SHORTER RECOVERY TIMES TO DRIVE MARKET
  • 8.5 ABDOMINOPLASTY
    INCREASING DESIRE FOR AESTHETIC IMPROVEMENTS TO PROMOTE GROWTH
  • 8.6 OTHER APPLICATIONS
BODY CONTOURING TREATMENTS MARKET, BY END USER
118
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    BOOMING MEDICAL TOURISM TO CONTRIBUTE TO MARKET GROWTH
  • 9.3 AESTHETIC CLINICS
    GROWING ESTABLISHMENT OF SPECIALTY CLINICS TO DRIVE MARKET
  • 9.4 MEDICAL SPAS & BEAUTY CENTERS
    RISING FOCUS ON BODY APPEARANCE TO AID GROWTH
BODY CONTOURING TREATMENTS MARKET, BY REGION
123
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Growing public acceptance of body contouring procedures to drive market
    CANADA
    - Rising inclination toward reducing signs of aging to aid growth
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing volume of aesthetic procedures to drive market
    FRANCE
    - Increasing demand for age-related aesthetic treatments to spur growth
    UK
    - Rising focus of men on body aesthetics to encourage growth
    ITALY
    - Gowing adoption of surgical procedures among young females to boost market
    SPAIN
    - Growing availability of high-quality and effective products to fuel market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Presence of medical aesthetic associations to spur growth
    CHINA
    - Increased availability of cosmetic surgery apps and online services to support growth
    INDIA
    - Increasing disposable income to contribute to market growth
    AUSTRALIA
    - Favorable government initiatives to promote growth
    SOUTH KOREA
    - Rising influx of foreign patients to facilitate growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Heightened awareness regarding body contouring enhancements to stimulate growth
    MEXICO
    - Increase in patient inflow from US to sustain growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
183
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BODY CONTOURING TREATMENTS MARKET
  • 11.3 REVENUE SHARE ANALYSIS, 2019−2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Technology footprint
    - Gender footprint
    - Application footprint
    - End-user footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
205
  • 12.1 KEY PLAYERS
    ABBVIE INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    INMODE LTD.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BAUSCH HEALTH COMPANIES INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CYNOSURE LUTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SISRAM MEDICAL LTD
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CUTERA, INC.
    - Business overview
    - Products offered
    - Recent developments
    EL.EN. S.P.A.
    - Business overview
    - Products offered
    VENUS CONCEPT
    - Business overview
    - Products offered
    - Recent developments
    SHARPLIGHT TECHNOLOGIES INC.
    - Business overview
    - Products offered
    - Recent developments
    SCITON
    - Business overview
    - Products offered
    - Recent developments
    CANDELA CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BTL INDUSTRIES
    - Business overview
    - Products offered
    - Recent developments
    FOTONA
    - Business overview
    - Products offered
    - Recent developments
    GZ MTS ELECTRONICS CO., LTD.
    - Business overview
    - Products offered
    ROHRER AESTHETICS, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    GBS INTERNATIONAL HOLDING LTD.
    SINCLAIR
    THERMI
    YOLO MEDICAL INC.
    DOMINION AESTHETIC TECHNOLOGIES, INC.
    ZIMMER MEDIZIN SYSTEME GMBH
    ERCHONIA CORPORATION
    CLASSYS INC.
    WON TECH CO., LTD.
    CELLSOUND AESTHETICS
APPENDIX
254
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 BODY CONTOURING TREATMENTS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 SURGICAL PROCEDURES PERFORMED ON MALE PATIENTS, 2021–2023
  • TABLE 3 NON-SURGICAL PROCEDURES PERFORMED ON MALE PATIENTS, 2021–2023
  • TABLE 4 AESTHETIC PLASTIC SURGEON FEES IN NORTH AMERICA, 2022 VS. 2023
  • TABLE 5 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2023
  • TABLE 6 NON-SURGICAL PROCEDURES, BY COUNTRY, 2023
  • TABLE 7 BODY CONTOURING TREATMENTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 8 US: MEDICAL DEVICE CLASSIFICATION
  • TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 10 US: CLASSIFICATION OF BODY CONTOURING DEVICES
  • TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
  • TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 14 REGULATORY APPROVALS FOR BODY CONTOURING DEVICES, BY COUNTRY
  • TABLE 15 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 MEDICAL REIMBURSEMENT CODES FOR BODY CONTOURING PROCEDURAL SERVICES IN US, 2023
  • TABLE 21 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TECHNOLOGY, 2023 (USD)
  • TABLE 22 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION, 2021–2023 (USD)
  • TABLE 23 IMPORT DATA FOR BODY CONTOURING DEVICES (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 24 IMPORT DATA FOR LASERS EXCLUDING LASER DIODES (HS CODE 901320), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 25 EXPORT DATA FOR BODY CONTOURING DEVICES (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 26 EXPORT DATA FOR LASER EXCLUDING LASER DIODES (HS CODE 901320), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 27 INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2021–AUGUST 2024
  • TABLE 28 BODY CONTOURING TREATMENTS MARKET: PORTER’S FIVE FORCES
  • TABLE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF BODY CONTOURING PRODUCTS
  • TABLE 30 INFLUENCE OF END USERS ON BUYING PROCESS, BY END USER
  • TABLE 31 BODY CONTOURING TREATMENTS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 32 BRAND MAPPING OF THERMAL TECHNOLOGIES
  • TABLE 33 BRAND MAPPING OF NON-THERMAL TECHNOLOGIES
  • TABLE 34 BODY CONTOURING TREATMENTS MARKET: CURRENT UNMET NEEDS
  • TABLE 35 BODY CONTOURING TREATMENTS MARKET: INTENSITY OF CURRENT UNMET NEEDS
  • TABLE 36 BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 37 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 38 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE RADIOFREQUENCY TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE LASER TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE ULTRASOUND TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 43 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE RADIOFREQUENCY TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE LASER TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE ULTRASOUND TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 BODY CONTOURING TREATMENTS MARKET FOR CRYOLIPOLYSIS TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 BODY CONTOURING TREATMENTS MARKET FOR OTHER NON-INVASIVE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 50 BODY CONTOURING PROCEDURES IN FEMALE PATIENTS, 2022 VS. 2023
  • TABLE 51 BODY CONTOURING TREATMENTS MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 BODY CONTOURING PROCEDURES IN MALE PATIENTS, 2022 VS. 2023
  • TABLE 53 BODY CONTOURING TREATMENTS MARKET FOR MALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 55 TOP 5 COUNTRIES PERFORMING NON-SURGICAL FAT REDUCTION TREATMENTS, 2018–2023
  • TABLE 56 BODY CONTOURING TREATMENTS MARKET FOR NON-SURGICAL FAT REDUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 BODY CONTOURING TREATMENTS MARKET FOR CELLULITE REDUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 TOP 5 COUNTRIES PERFORMING LIPOSUCTION PROCEDURES, 2018–2023
  • TABLE 59 BODY CONTOURING TREATMENTS MARKET FOR LIPOSUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 TOP 5 COUNTRIES PERFORMING ABDOMINOPLASTY TREATMENTS, 2018–2023
  • TABLE 61 BODY CONTOURING TREATMENTS MARKET FOR ABDOMINOPLASTY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 BODY CONTOURING TREATMENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 64 BODY CONTOURING TREATMENTS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 BODY CONTOURING TREATMENTS MARKET FOR AESTHETIC CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 BODY CONTOURING TREATMENTS MARKET FOR MEDICAL SPAS & BEAUTY CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 BODY CONTOURING TREATMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 74 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 75 KEY MACROINDICATORS FOR NORTH AMERICA
  • TABLE 76 US: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 77 US: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 US: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 BODY CONTOURING PROCEDURES CONDUCTED IN US, 2020–2023
  • TABLE 80 CANADA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 81 CANADA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 CANADA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 83 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 85 EUROPE: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 EUROPE: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 89 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 90 KEY MACROINDICATORS FOR EUROPE
  • TABLE 91 BODY CONTOURING PROCEDURES CONDUCTED IN GERMANY, 2020–2023
  • TABLE 92 GERMANY: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 93 GERMANY: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 GERMANY: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 FRANCE: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 96 FRANCE: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 FRANCE: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 BODY CONTOURING PROCEDURES CONDUCTED IN UK, 2022–2023
  • TABLE 100 UK: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 101 UK: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 UK: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 BODY CONTOURING PROCEDURES CONDUCTED IN ITALY, 2020–2023
  • TABLE 104 ITALY: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 105 ITALY: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 ITALY: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 BODY CONTOURING PROCEDURES CONDUCTED IN SPAIN, 2021–2023
  • TABLE 108 SPAIN: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 109 SPAIN: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 SPAIN: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 REST OF EUROPE: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 112 REST OF EUROPE: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 REST OF EUROPE: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 119 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 120 KEY MACROINDICATORS FOR ASIA PACIFIC
  • TABLE 121 BODY CONTOURING PROCEDURES CONDUCTED IN JAPAN, 2020–2022
  • TABLE 122 JAPAN: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 123 JAPAN: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 JAPAN: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 CHINA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 126 CHINA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 CHINA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 BODY CONTOURING PROCEDURES CONDUCTED IN INDIA, 2020–2023
  • TABLE 129 INDIA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 130 INDIA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 INDIA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 AUSTRALIA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 133 AUSTRALIA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 AUSTRALIA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 SOUTH KOREA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 136 SOUTH KOREA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 SOUTH KOREA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 REST OF ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 139 REST OF ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 REST OF ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 142 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 147 KEY MACROINDICATORS FOR LATIN AMERICA
  • TABLE 148 BODY CONTOURING PROCEDURES CONDUCTED IN BRAZIL, 2020–2023
  • TABLE 149 BRAZIL: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 150 BRAZIL: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 BRAZIL: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 MEXICO: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 153 MEXICO: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 MEXICO: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 BODY CONTOURING PROCEDURES CONDUCTED IN ARGENTINA, 2020–2023
  • TABLE 156 REST OF LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 157 REST OF LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 REST OF LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 160 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 165 KEY MACROINDICATORS FOR MIDDLE EAST & AFRICA
  • TABLE 166 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BODY CONTOURING TREATMENTS MARKET
  • TABLE 167 BODY CONTOURING TREATMENTS MARKET: DEGREE OF COMPETITION
  • TABLE 168 BODY CONTOURING TREATMENTS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 169 BODY CONTOURING TREATMENTS MARKET: GENDER FOOTPRINT
  • TABLE 170 BODY CONTOURING TREATMENTS MARKET: APPLICATION FOOTPRINT
  • TABLE 171 BODY CONTOURING TREATMENTS MARKET: END-USER FOOTPRINT
  • TABLE 172 BODY CONTOURING TREATMENTS MARKET: REGION FOOTPRINT
  • TABLE 173 BODY CONTOURING TREATMENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 174 BODY CONTOURING TREATMENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 175 BODY CONTOURING TREATMENTS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 176 BODY CONTOURING TREATMENTS MARKET: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 177 BODY CONTOURING TREATMENTS MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 178 ABBVIE INC.: COMPANY OVERVIEW
  • TABLE 179 ABBVIE INC.: PRODUCTS OFFERED
  • TABLE 180 ABBVIE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 181 INMODE LTD.: COMPANY OVERVIEW
  • TABLE 182 INMODE LTD.: PRODUCTS OFFERED
  • TABLE 183 INMODE LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− AUGUST 2024
  • TABLE 184 INMODE LTD.: DEALS, JANUARY 2021− AUGUST 2024
  • TABLE 185 BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW
  • TABLE 186 BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED
  • TABLE 187 BAUSCH HEALTH COMPANIES INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 188 CYNOSURE LUTRONIC: COMPANY OVERVIEW
  • TABLE 189 CYNOSURE LUTRONIC: PRODUCTS OFFERED
  • TABLE 190 CYNOSURE LUTRONIC: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 191 SISRAM MEDICAL LTD: COMPANY OVERVIEW
  • TABLE 192 SISRAM MEDICAL LTD: PRODUCTS OFFERED
  • TABLE 193 SISRAM MEDICAL LTD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− AUGUST 2024
  • TABLE 194 SISRAM MEDICAL LTD: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 195 SISRAM MEDICAL LTD: EXPANSIONS, JANUARY 2021−AUGUST 2024
  • TABLE 196 CUTERA, INC.: COMPANY OVERVIEW
  • TABLE 197 CUTERA, INC.: PRODUCTS OFFERED
  • TABLE 198 CUTERA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 199 EL.EN. S.P.A.: COMPANY OVERVIEW
  • TABLE 200 EL.EN. S.P.A.: PRODUCTS OFFERED
  • TABLE 201 EL.EN. S.P.A.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 202 VENUS CONCEPT: COMPANY OVERVIEW
  • TABLE 203 VENUS CONCEPT: PRODUCTS OFFERED
  • TABLE 204 VENUS CONCEPT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 205 VENUS CONCEPT: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 206 SHARPLIGHT TECHNOLOGIES INC.: COMPANY OVERVIEW
  • TABLE 207 SHARPLIGHT TECHNOLOGIES INC.: PRODUCTS OFFERED
  • TABLE 208 SHARPLIGHT TECHNOLOGIES INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 209 SCITON: COMPANY OVERVIEW
  • TABLE 210 SCITON: PRODUCTS OFFERED
  • TABLE 211 SCITON: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 212 CANDELA CORPORATION: COMPANY OVERVIEW
  • TABLE 213 CANDELA CORPORATION: PRODUCTS OFFERED
  • TABLE 214 CANDELA CORPORATION: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 215 BTL INDUSTRIES: COMPANY OVERVIEW
  • TABLE 216 BTL INDUSTRIES: PRODUCTS OFFERED
  • TABLE 217 BTL INDUSTRIES: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 218 BTL INDUSTRIES: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 219 FOTONA: COMPANY OVERVIEW
  • TABLE 220 FOTONA: PRODUCTS OFFERED
  • TABLE 221 FOTONA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 222 GZ MTS ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 223 GZ MTS ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 224 ROHRER AESTHETICS, INC.: COMPANY OVERVIEW
  • TABLE 225 ROHRER AESTHETICS, INC.: PRODUCTS OFFERED
  • TABLE 226 ROHRER AESTHETICS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 227 ROHRER AESTHETICS, INC.: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 228 GBS INTERNATIONAL HOLDING LTD.: COMPANY OVERVIEW
  • TABLE 229 SINCLAIR: COMPANY OVERVIEW
  • TABLE 230 THERMI: COMPANY OVERVIEW
  • TABLE 231 YOLO MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 232 DOMINION AESTHETIC TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 233 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
  • TABLE 234 ERCHONIA CORPORATION: COMPANY OVERVIEW
  • TABLE 235 CLASSYS INC.: COMPANY OVERVIEW
  • TABLE 236 WON TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 237 CELLSOUND AESTHETICS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 BODY CONTOURING TREATMENTS MARKET SEGMENTATION
  • FIGURE 2 BODY CONTOURING TREATMENTS MARKET: RESEARCH DESIGN
  • FIGURE 3 BODY CONTOURING TREATMENTS MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY-SIDE PARTICIPANTS)
  • FIGURE 4 BODY CONTOURING TREATMENTS: KEY INSIGHTS FROM PRIMARY INTERVIEWS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 8 BODY CONTOURING TREATMENTS MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 9 BODY CONTOURING TREATMENTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 BODY CONTOURING TREATMENTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 BODY CONTOURING TREATMENTS MARKET, BY REGION, 2024–2029 (CAGR)
  • FIGURE 17 GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES TO DRIVE MARKET
  • FIGURE 18 NON-INVASIVE TECHNOLOGIES SEGMENT TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 19 AESTHETIC CLINICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 20 ABDOMINOPLASTY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 22 BODY CONTOURING TREATMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 NON-SURGICAL PROCEDURES PERFORMED GLOBALLY, 2023 VS. 2022
  • FIGURE 24 BODY CONTOURING TREATMENTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 BODY CONTOURING TREATMENTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 26 BODY CONTOURING TREATMENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 27 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
  • FIGURE 28 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 29 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 30 INVESTMENT AND FUNDING SCENARIO IN BODY CONTOURING TREATMENTS MARKET, 2019−2023 (USD MILLION)
  • FIGURE 31 NUMBER OF INVESTOR DEALS IN BODY CONTOURING TREATMENTS MARKET, BY KEY PLAYER, 2019−2023 (UNIT)
  • FIGURE 32 VALUE OF INVESTOR DEALS IN BODY CONTOURING TREATMENTS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
  • FIGURE 33 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY, 2023
  • FIGURE 34 AVERAGE SELLING PRICE TREND OF BODY CONTOURING DEVICES, BY REGION, 2023
  • FIGURE 35 BODY CONTOURING TREATMENTS MARKET: PATENT ANALYSIS, 2013–2023
  • FIGURE 36 BODY CONTOURING TREATMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY CONTOURING PRODUCTS
  • FIGURE 38 KEY BUYING CRITERIA, BY END USER
  • FIGURE 39 NEW REVENUE POCKETS FOR PLAYERS IN BODY CONTOURING TREATMENTS MARKET
  • FIGURE 40 MARKET POTENTIAL OF AI/GENERATIVE AI ON BODY CONTOURING TREATMENTS MARKET
  • FIGURE 41 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET SNAPSHOT
  • FIGURE 42 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET SNAPSHOT
  • FIGURE 43 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN BODY CONTOURING TREATMENTS MARKET, 2019−2023
  • FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 45 RANKING OF KEY PLAYERS IN BODY CONTOURING TREATMENTS MARKET, 2023
  • FIGURE 46 BODY CONTOURING TREATMENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 47 BODY CONTOURING TREATMENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 48 BODY CONTOURING TREATMENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 50 EV/EBITDA OF KEY VENDORS
  • FIGURE 51 BODY CONTOURING TREATMENTS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 52 ABBVIE INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 INMODE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 SISRAM MEDICAL LTD: COMPANY SNAPSHOT (2023)
  • FIGURE 56 CUTERA, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 57 EL.EN. S.P.A.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 VENUS CONCEPT: COMPANY SNAPSHOT (2023)

The study involved four major activities in estimating the current size of the body contouring treatments market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial body contouring treatments market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as Chief Executive Officers (CEOs), vice presidents (VPs), marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the body contouring treatments market. The primary sources from the demand side include hospitals, aesthetic clinics, medical spas, beauty centers and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The tiers of the companies are defined based on their total revenue. As of 2023: Tier 1 => USD 1 billion, Tier 2 = USD 200-500 million to USD 1 billion, and Tier 3 =< USD 200 million

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the body contouring treatments market.These methods were also used extensively to estimate the size of various subsegments in the market . The research metholody used to estimate the market size includes the following:

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the body contouring treatments market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the body contouring treatments market was validated using top-down and bottom-up approaches.

Market Definition

Body contouring is a medical process to reshape a body part, which involves removing excess skin, eliminating extra fat, and reforming or sculpting the area. The majority of body parts can be targeted by body contouring. The common sites include arms, buttocks, thighs, back and belly. The products are utilized for multiple applications, including non-surgical fat reduction, liposuction, cellulite treatment, etc. The primary end users of this market are hospitals, aesthetic clinics, medical spas, and beauty centers.

Stakeholders

  • Body Contouring Device Manufacturers
  • Medical Spas and Beauty centers
  • Pharmaceutical Companies
  • Aesthetic Clinics
  • Hospitals
  • Body Contouring Device Distributors and Suppliers
  • Aesthetic Surgeons

Report Objectives

  • To define, describe, and forecast the body contouring treatments market based on technology, application, patient type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
  • To profile the key players and comprehensively analyze their market ranking and core competencies
  • To benchmark players within the market using a proprietary competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of  market share and product footprint

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Body Contouring Treatments Market

DMCA.com Protection Status